These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8088690)

  • 1. [Cell therapy and its risks].
    Bohl JR; Goebel HH; Pötsch L; Walther G; Mattern R
    Fortschr Med; 1994 Jun; 112(18):261-5. PubMed ID: 8088690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications following cell therapy].
    Bohl J; Goebel HH; Pötsch L; Esinger W; Walther G; Mattern R; Merkel KH
    Z Rechtsmed; 1989; 103(1):1-20. PubMed ID: 2588815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causes of the syndromes of Landry (1859) and of Guillain, Barré and Strohl (1916).
    Alvord EC; Jahnke U; Fischer EH
    Rev Neurol (Paris); 1987; 143(8-9):571-9. PubMed ID: 2445014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pathogenesis of postinfectious encephalomyelitis and polyradiculoneuritis].
    Ohara Y
    Nihon Rinsho; 1997 Apr; 55(4):800-4. PubMed ID: 9103874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset of Guillain-Barré syndrome.
    Poser CM; Behan PO
    J Neuroimmunol; 1982 Aug; 3(1):27-41. PubMed ID: 6124552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polyneuropathy: Guillain-Barre syndrome].
    Ishihara Y
    Nihon Rinsho; 1982; 40(7):1509-20. PubMed ID: 7176108
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of monoamine reuptake inhibiting antidepressants in experimental allergic neuritis.
    Zhu J; Mix E; Bengtsson BO; Link H
    J Peripher Nerv Syst; 1997; 2(1):30-42. PubMed ID: 10975734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
    Zhang Z; Zhang ZY; Schluesener HJ
    J Immunol; 2009 Sep; 183(5):3081-91. PubMed ID: 19675162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system.
    Croxford JL; Triantaphyllopoulos K; Podhajcer OL; Feldmann M; Baker D; Chernajovsky Y
    J Immunol; 1998 May; 160(10):5181-7. PubMed ID: 9590271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome.
    Racke MK; Quigley L; Cannella B; Raine CS; McFarlin DE; Scott DE
    J Immunol; 1994 Feb; 152(4):2051-9. PubMed ID: 8120406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2 cases of death following cell therapy].
    de Ridder M; Dienemann D; Dissmann W; Goebel HH; Merkel KH; Meuth M; Stein H
    Dtsch Med Wochenschr; 1987 Jun; 112(25):1006-9. PubMed ID: 2954809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.
    Falcone M; Rajan AJ; Bloom BR; Brosnan CF
    J Immunol; 1998 May; 160(10):4822-30. PubMed ID: 9590229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.
    Araga S; Kishimoto M; Doi S; Nakashima K
    J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guillain-Barré syndrome after injection of sheep cells].
    Susel Z; Szwarc M
    Harefuah; 1988 Jun; 114(11):536-8. PubMed ID: 3396990
    [No Abstract]   [Full Text] [Related]  

  • 18. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
    Lonigro A; Devaux JJ
    Brain; 2009 Jan; 132(Pt 1):260-73. PubMed ID: 18953054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis.
    Dal Canto RA; Costa G; Shaw MD; Seroogy C; Nolan GP; Fathman CG
    Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):83-91. PubMed ID: 9831193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration.
    Pilartz M; Jess T; Indefrei D; Schröder JM
    Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.